A Multi-center, Observational, Cross-sectional Study to Evaluate CVD Risk Factors in Korean Hypertensive Patients

GlaxoSmithKline0 sites3,109 target enrollmentAugust 2010

ConditionsHypertension

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hypertension
Sponsor: GlaxoSmithKline
Enrollment: 3109
Primary Endpoint: Proportion of patients with cardiovascular disease high risk factors
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.

Detailed Description

Primary endpoint: To evaluate the Proportion of patients with Cardiovascular disease high risk factors Secondary endpoint: To evaluate the Proportion of patients with Cardiovascular disease risk factors, To evaluate the Proportion of patients with Cardiovascular disease, To evaluate Target blood pressure achievement rate according to the proportion of Cardiovascular disease risks

Registry

clinicaltrials.gov

Start Date

August 2010

End Date

January 2011

Last Updated

9 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

GlaxoSmithKline

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Essential hypertensive patient no less than 18 yeas old
•Patient who gave informed consent form

Exclusion Criteria

•Patient was diagnosed as secondary hypertension
•Patient who have white-coat hypertension

Outcomes

Primary Outcomes

Proportion of patients with cardiovascular disease high risk factors

Time Frame: 6years, average duration of hypertension

Between patients with essential hypertension

Secondary Outcomes

Proportion of patients with Cardiovascular disease(6years, average duration of hypertension)
Proportion of patients with Cardiovascular disease risk factors(6years, average duration of hypertension)
Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks(6years, average duration of hypertension)